← Eichor
Condition: Islet Cell Tumor Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Islet Cell Tumor

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Registry of Endocrine Tumors (Thyroid, Parathyroid, Adrenal, Endocrine Pancreas, Endocrine Digestive Tube)
Phase N/A · 1 location(s) · Central Hospital, Nancy, France · NCT03410394Diagnosing and Treating Low Blood Sugar Levels
Phase N/A · 1 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT00001276A Trial to Assess Efficacy, Safety, Pharmacokinetics of Octreotide Subcutaneous Injection in Patients With Gastroentero-
Phase 2 · 1 location(s) · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · NCT06505395Utility of 18FDOPA PET/MRI for Focal Hyperinsulinism
Phase 2 · 1 location(s) · Washington University School of Medicine · NCT05088798Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Phase 2/Phase 3 · 117 location(s) · Exelixis · NCT06943755Spanish Series of Patients Treated With the Radionuclide Lutetium177
Phase N/A · 20 location(s) · Sociedad Española de Medicina Nuclear e Imagen Molecular · NCT04949282Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.
Phase 1 · 9 location(s) · RayzeBio, Inc. · NCT07165132Pancreatic Cancer Screening Through the Detection of Elastase-1 Combined With Other Examinations
Phase N/A · 1 location(s) · Qilu Hospital of Shandong University · NCT06041009Study to Test the Combination of Fulvestrant With Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors
Phase 1 · 1 location(s) · University of Chicago · NCT06663072Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma
Phase 1 · 1 location(s) · Cook Children's Health Care System · NCT02021604Pancreatic Radiofrequency Under High Echo-endoscopy in the Management of Pancreatic Neuroendocrine Tumors
NA · 1 location(s) · Institut Paoli-Calmettes · NCT04520932Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
Phase N/A · 3 location(s) · Mayo Clinic · NCT00830557Safety and Efficacy of EUS-RFA in Pancreatic Insulinoma
Phase N/A · 1 location(s) · Sahlgrenska University Hospital · NCT07585032Plasma cfDNA Fragmentomics for Early pNET Detection and Differential Diagnosis of Solid Pancreatic Tumors
Phase N/A · 2 location(s) · Fudan University · NCT05847855Endoscopic Ultrasound-guided Radiofrequency Ablation for Upper Gastrointestinal Tract Lesions
Phase N/A · 1 location(s) · Herlev Hospital · NCT07272187Development of New Personalised 3D Preclinical Models of Pancreatic Neuroendocrine Tumours
Phase N/A · 1 location(s) · IRCCS San Raffaele · NCT06121622Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients
Phase N/A · 3 location(s) · Universidad Nacional Autonoma de Mexico · NCT06523582Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)
NA · 1 location(s) · Shanghai Jiao Tong University School of Medicine · NCT06141369Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors
Phase 1 · 10 location(s) · National Cancer Institute (NCI) · NCT05687123Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objective
NA · 1 location(s) · M.D. Anderson Cancer Center · NCT01365169Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
Phase 2 · 448 location(s) · SWOG Cancer Research Network · NCT05040360Genetic Predisposition Testing Program for Pancreatic Neuroendocrine Neoplasms
Phase N/A · 3 location(s) · University of California, San Francisco · NCT05746182A Clinical Study of Sorafenib Combined With Gefitinib for the Treatment of pNET
Phase N/A · 1 location(s) · Shanghai General Hospital, Shanghai Jiao Tong University Sch · NCT06592989Outcomes After Laparoscopic Versus Open Pancreaticoduodenectomy
NA · 1 location(s) · Minia University · NCT07328607Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor
Phase 2 · 84 location(s) · Merck Sharp & Dohme LLC · NCT04924075Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors
Phase 2 · 2 location(s) · AC Camargo Cancer Center · NCT06472388A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
Phase 3 · 13 location(s) · Rezolute · NCT06881992Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 17
Phase 3 · 54 location(s) · RayzeBio, Inc. · NCT05477576Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients With Progressing Metastatic Neuro
Phase 2 · 1 location(s) · Roswell Park Cancer Institute · NCT06202066Precision Radiotherapy Using MR-linac for Pancreatic Neuroendocrine Tumours in MEN1 Patients
NA · 1 location(s) · J.M. de Laat · NCT05037461
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.